Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment oF Severe Asthma

NCT02872298 is registered in ClinicalTrials.gov with Nuvaira, Inc. as lead sponsor.

NCT NCT02872298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02872298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment oF Severe Asthma
Lead sponsor
Nuvaira, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
December 22, 2017
Completion date
April 6, 2020
Enrollment
2 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

asthma